Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Circulating Tumor Cells

Enal Razvi's Biography

Enal Razvi, Managing Director, Select Biosciences Inc

Enal Razvi, PhD is biotechnology analyst and Managing Director US at Select Biosciences. In this capacity he continuously tracks a number of fields in the scope of his industry coverage, authors market analysis reports in these areas, and works with companies worldwide in the areas of technology analysis, market research, strategy development, and operational roles. Dr. Razvi holds a doctoral degree in the biomedical sciences and was post-doctoral fellow under Ralph Steinman [Nobel Laureate in 2011] at The Rockefeller University, New York. For the last decade, Dr. Razvi has been focused on tracking the life sciences fields and has worked with numerous companies around the world.

Dr. Razvi can be reached at:

Enal Razvi Image

CTCs: Analysis of Market Trends and Clinical Utility

Tuesday, 22 January 2013 at 11:15

Add to Calendar ▼2013-01-22 11:15:002013-01-22 12:15:00Europe/LondonCTCs: Analysis of Market Trends and Clinical

Select Biosciences has been tracking the circulating tumor cells (CTCs) marketplace from the perspective of technology trends, market trends, and analysis of clinical utility.  This presentation presents a snapshot of our most up-to-date market analyses excerpted from Select Biosciences Circulating Tumor Cells 2013 Market Report.

Add to Calendar ▼2013-01-22 00:00:002013-01-23 00:00:00Europe/LondonCirculating Tumor